A CT method to measure hemodynamics in brain tumors: Validation and application of cerebral blood flow maps

American Journal of Neuroradiology

Volumn 21, Issue 3, 2000, Pages 462-470

  Cenic, Aleksa ^a,b,c   Nabavi, Darius G ^a   Craen, Rosemary A ^d   Gelb, Adrian W ^d   Lee, Ting Yim ^a,b,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION FUNCTION; HEMODYNAMICS; MALE; NONHUMAN; TUMOR DIAGNOSIS;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD VOLUME; BRAIN NEOPLASMS; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; CINERADIOGRAPHY; CONTRAST MEDIA; MALE; MICROSPHERES; NEOPLASM TRANSPLANTATION; RABBITS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034069356     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schwartz RB. Neuroradiology of brain tumors. Neurol Clin 1995;13:723-756
2. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evlauation of positron emission tomography? AJNR Am J Neuroradiol 1998;19:407-413
3. Yoshi Y, Moritake T, Suzuki K, Fujita K, Nose T, Satou M. Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. AJNR Am J Neuroradiol 1996; 17:1773-1776
4. Kline JL, Noto RB, Glantz M. Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. AJNR Am J Neuraradiol 1996;17:1681-1686
5. Levivier M, Becerra A, DeWitte O, Brotchi J, Goldman S. Radiation necrosis or recurrence. J Neurosurg 1996;84:148-149
6. Lammertsma AA, Wise RJS, Jones T. In vivo measurements of regional cerebral blood flow and blood volume in patients with brain tumors using positron emission tomography. Acta Neurochirurgica 1983;69:5-13
7. Bergstrom M, Collins VP, Ehrin E, et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68-Ga] EDTA, [11-C] glucose, and [11-C] methionine. JCAT 1983;7:1062-1066
8. Patronas NJ, Di Chiro G, Brooks RA, et al. Work in progress: [18F] Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982;144:885-889
9. Patronas NJ, Di Chiro G, Kufta C, et al. Predictions of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816
10. Di Chiro G, DeLa Paz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329
11. Carvalho PA, Schwartz RB, Alexander E, et al. Extracranial metastatic glioblastoma: Appearance on thallium-201 cloride/ technetium-99m HMPAO SPECT IMAGES. J Nucl Med 1991; 32:322-324
12. Carvalho PA, Schwartz RB, Alexander EA HI, et al. Detection of recurrent gliomas with qualitative thallium-201 / technetium-99m HMPAO single-photon emission computed tomography. J Neurosurg 1992;77:565-574
13. Schwartz RB, Carvalho PA, Alexander EA III, et al. Radiation necrosis vs. high grade glioma: Differentiation by using dual-isotope SPECT with 201-T1 and 99m-Tc HMPAO. AJNR Am J Neuroradiol 1991;12:1187-1192
14. Aronen HJ, Cohen MS, Belliveau JW, et al. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14-24
15. Dean BL, Lee C, Kirsch JE, et al. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted turbo-FLASH imaging. AJNR Am J Neuroradiol 1992;13:39-48
16. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee T-Y. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63-73
17. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography. A theoretical analysis. Radiology 1980; 137:679-686
18. Drayer BP. Functional applications of CT of the central nervous system. AJNR Am J Neuroradiol 1981;2:495-510
19. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731-744
20. St. Lawrence KS, Lee T-Y. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Metab 1998;18:1365-1377
21. Bassingthwaighte JB, Chinard FP, Crone C, Lassen NA, Perl W. Definitions and terminology for indicator dilution methods. In: Crone C, Lassen NA, eds. Capillary Permeability. Copenhagen: Munskgaard; 1970
22. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscle. Am J Physiol 1959;197: 1205-1210
23. Crone C. Permeability of capillaries in various organs as determined by use of the indicator diffusion methods. Acta Physiol Scand 1963;58:292-305
24. Todd MM, Weeks JB, Warner DS. Microwave fixation for the determination of cerebral blood volume in rats. J Cereb Blood Flow Metab 1993;13:328-336
25. Carson BS, Anderson JH, Grossman SA, et al. Improved rabbit brain tumor model amenable to diagnostic radiographic procedures. Neurosurgery 1982;11:603-608
26. Zagzag D, Brem S, Robert F. Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. Am J Pathol 1988;131: 361-372
27. Dewitt DS, Fatouros PP, Wist AO, et al. Stable xenon versus radiolabeled microsphere cerebral blood flow measurements in baboons. Stroke 1989;20:1716-1723
28. Endo H, Larsen B, Lassen NA. Regional cerebral blood flow alterations remote from the site of intracranial tumors. J Neurosurg 1977;46:271-281
29. Brooks DJ, Beaney RP, Lammertsma AA, et al. Quantitative measurement of blood-brain-barrier permeability using 82-Rb and positron emission tomography. J Cereb Blood Flow Metab 1984;4:535-545
30. Jarden JO. Pathophysiological aspects of malignant brain tumors studied with positron emission tomography. Acta Neurologica Scandinavica 1995;156:1-34
31. Yeung WT, Lee T-Y, Del Maestro RF, Kozak R, Bennett J, Brown T. Effect of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with X-ray computed tomography. J Neuro Oncol 1994;8:53-60
32. Fike JR, Gobbel GT, Mesiwala AH, et al. Cerebrovascular effects of the bradykinin analog RMP-7 in normal and irradiated dog brain. J Neuro Oncol 1998;37:199-215
33. Hamberg LM, Hunter GJ, Halpern EF, Hoop B, Gazelle GS, Wolf GL. Quantitative high-resolution measurement of cerebrovascular physiology with slip-ring CT. AJNR Am J Neuroradiol 1996;17:639-650
34. Steiger HJ, Aaslid R, Stooss R. Dynamic computed tomography imaging of regional cerebral blood flow and blood volume. A clinical pilot study. Stroke 1993;24:591-597
35. Gamel J, Rousseau WF, Katholi CR, Mesel E. Pitfalls in digital computation of the impulse response of vascular beds from indicator dilution curves. Circ Res 1973;32:516-523
36. Bronikowski TA, Dawson CA, Linehan JH. Model-free deconvolution techniques for estimating vascular transport functions. Int J Biomed Comput 1983;14:411-429
37. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol 1983;18:94-99
38. Nabavi DG, Cenic A, Craen RA, Gelb AW, Lee T-Y. CT Assessment of Cerebral Perfusion in Man. Experimental validation and initial clinical experience. Radiology 1999;213:141-149
39. Huda W, Sandison GA, Lee TY. Energy imparted and effective doses in computed tomography. Med Phys 1996;23:735-741
40. E, in positron emission tomography studies. Eur J Nucl Med 1990;17:116-120
41. E, for 99mTc labelled radiopharmaceuticals. Eur J Nucl Med 1989;15:174-179
42. Johnson DW, Marks MP, Good WF, Stringer WA, Yonas H, Gur D. Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making. AJNR Am J Neuroradiol 1991;12:201-213
43. Palvolgyi R. Regional cerebral blood flow in patients with intracranial tumors. J Neurosurg 1969;31:149-163